Stay updated with breaking news from Circle Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wayne, PA (PRWEB) January 05, 2022 -- Bio-IT computing consultancy and services firm RCH Solutions (RCH) announces that it achieved a number of milestones as
Circle Pharma Raises $66M in Series C Financing Circle Pharma, Inc., a South San Francisco, Calif.-based macrocycle drug discovery and development company focused on intractable cancer targets, raised $66m in Series C financing. The round was co-led by The Column Group and Nextech Invest with participation from Pandect Bioventures, together with new investors including Euclidean Capital, Pavillion Capital, Hartford HealthCare Endowment and Eli Lilly and Company. The company intends to use the funds to advance its wholly owned cyclin-targeted programs towards the clinic, with potential applica...
Published: Feb 01, 2021 SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Constantine Kreatsoulas, PhD has joined Circle Pharma, Inc. as its Vice President of Research Informatics and Computational Chemistry. Dr. Kreatsoulas joins Circle from GlaxoSmithKline (GSK) where he was the Head of US Molecular Design and Interim Head of Computational Toxicology. His responsibilities at GSK included leading structure-based drug design (SBDD) teams and the development of informatics tools for quantitative experimental data analytics and drug hazard identification. Previously he was a Research Fel...